0001958244-24-003921.txt : 20240813 0001958244-24-003921.hdr.sgml : 20240813 20240813172023 ACCESSION NUMBER: 0001958244-24-003921 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 241203016 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: BFI Co., LLC CENTRAL INDEX KEY: 0001601607 ORGANIZATION NAME: IRS NUMBER: 262105186 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 300 FRANK W. BURR BLVD., STE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 2013297300 MAIL ADDRESS: STREET 1: 300 FRANK W. BURR BLVD., STE 21 CITY: TEANECK STATE: NJ ZIP: 07666 144 1 primary_doc.xml 144 0001601607 XXXXXXXX LIVE 0001069899 Phibro Animal Health Corporation 001-36410 Glenpointe Centre East, 3rd Floor 300 Frank W. Burr Boulevard, Suite 21 Teaneck NJ 07666 1-201-329-7300 BFI Co., LLC 10% Stockholder Class A Common Share Goldman Sachs & Co. LLC 200 West Street New York NY 10282 257400 4450446 20337574 08/13/2024 NASD Class A Common Stock 04/14/2014 Private placement from issuer of securities Phibro Animal Health Corporation N 257400 04/14/2014 Exchange of Securities Y The sales of shares set forth herein are made in connection with a selling plan dated 2/12/2024 that is intended to comply with Rule 10b5-1(c). The representation below regarding the seller's knowledge of material information was true as of the date the selling plan was entered into. 08/13/2024 02/12/2024 Goldman Sachs & Co. LLC on behalf of Jack Bendheim